✦ LIBER ✦

547 INHIBITION OF HEPATITIS B VIRUS REPLICATION IN VIVO BY A NOVEL NON-NUCLEOSIDIC COMPOUND

✍ Scribed by X. Wang; D. Jiang; H.Y. Zhang; F. Liu; H.H. Zhang; X. Xie; L. Wei; H. Chen

Book ID: 117380759
Publisher: Elsevier Science
Year: 2012
Tongue: English
Weight: 57 KB
Volume: 56
Category: Article
ISSN: 0168-8278
DOI: 10.1016/s0168-8278(12)60560-1

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

1030 INHIBITION OF HUMAN HEPATITIS B VIR

1030 INHIBITION OF HUMAN HEPATITIS B VIRUS (HBV) BY A NOVEL NON-NUCLEOSIDIC COMPOUND

✍ Wang, X.-Y.; Wang, J.-H.; Zhang, H.-H.; Fei, R.; Wei, L.; Wang, Y.; Chen, H.-S. 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 49 KB

Inhibition of human hepatitis B virus (H

Inhibition of human hepatitis B virus (HBV) by a novel non-nucleosidic compound in a transgenic mouse model

✍ O. Weber; K.-H. Schlemmer; E. Hartmann; Ina Hagelschuer; A. Paessens; E. Graef; 📂 Article 📅 2002 🏛 Elsevier Science 🌐 English ⚖ 324 KB

Inhibition of hepatitis B virus replicat

Inhibition of hepatitis B virus replication in vivo by nucleoside analogues and siRNA

✍ C Klein; C.T Bock; H Wedemeyer; T Wüstefeld; S Locarnini; H.P Dienes; S Kubicka; 📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 451 KB

Inhibition of murine cytomegalovirus and

Inhibition of murine cytomegalovirus and human cytomegalovirus by a novel non-nucleosidic compound in vivo

✍ Olaf Weber; Wolfgang Bender; Peter Eckenberg; Siegfried Goldmann; Michael Haerte 📂 Article 📅 2001 🏛 Elsevier Science 🌐 English ⚖ 269 KB

Non-cytolytic inhibition of hepatitis B

Non-cytolytic inhibition of hepatitis B virus replication in humanhepatocytes

✍ D. Suri; R. Schilling; A. Lopes; G. Colucci; R. Williams; N.V. Naoumov 📂 Article 📅 2000 🏛 Elsevier Science 🌐 English ⚖ 175 KB

Inhibition of hepatitis A virus replicat

Inhibition of hepatitis A virus replication in vitro by antiviral compounds

✍ J. M. Crance; E. Biziagos; J. Passagot; H. van Cuyck-Gandré; Dr. R. Deloince 📂 Article 📅 1990 🏛 John Wiley and Sons 🌐 English ⚖ 645 KB

## Abstract Forty antiviral compounds were screened for inhibitory effect on hepatitis A virus (HAV) antigen expression in the human hepatoma cell line PLC/PRF/5. Ribavirin, amantadine, glycyrrhizin, and pyrazofurin were selected in this screening test and were studied further. The selectivity indi